MainNumber of marketing applications received in the monthMarketing Applications (New Drug Applications (NDA) and Biologics License Applications (BLA) are applications to request permission to market a product in the U.S. for a specific use; these applications have legislatively mandated timelines for review.<br>These measures have been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research. </b>Number02010Measure was implemented starting January 201002011FY 2011 Total: 116402012FY 2012 YTD: 39MainTotal number of actions taken on marketing applications during the monthNumber02010Measure was implemented starting January 201002011FY 2011 Total: 121402012FY 2012 YTD: 28SubTotal number of actions taken on marketing applications during the monthNumber of actions taken on marketing applications in the month that were within goal datesNumber0202010Measure was implemented starting January 20100202011FY 2011 Total: 1152012FY 2012 YTD: 26SubTotal number of actions taken on marketing applications during the monthNumber of actions taken on marketing applications in the month that were past goal datesNumber0202010Measure was implemented starting January 20100202011FY 2011 Total: 60202012FY 2012 YTD: 2MainFor those actions taken past goal deadlines, median number of days past the goal dateNumbercolumn02010Measure was implemented starting January 2010020112012MainNumber of overdue applications at the end of the monthNumber02010Measure was implemented starting January 201002011FY 2011 Total: 13202012FY 2012 YTD: 5http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htmFDA-TRACK CDER Dashboardhttphttp://www.fda.gov/drugs/informationondrugs/default.htmDrug Approvals and Databases